Amarin reported $338.6M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
AstraZeneca USD 301.25B 13.1B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
DBV Technologies USD 274M 17M Sep/2025
Esperion Therapeutics USD 885M 351M Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Novartis USD 307.76B 15.54B Mar/2026